These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4439302)

  • 1. [Prophylactic use of cardiac glycosides in patients with ischemic heart disease].
    Komarov FI; Rabkin IKh; Ol'binskaia LI; Kitaeva IT; Abugov AM
    Ter Arkh; 1974; 46(9):29-35. PubMed ID: 4439302
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of cardiac glycosides and anabolic preparations on the indices of the blood oxygen balance and carbohydrate metabolism in ischemic heart disease patients in the initial (preclinical) stage of heart failure].
    Denisiuk VI; Shkliar MB
    Ter Arkh; 1984; 56(4):64-7. PubMed ID: 6729733
    [No Abstract]   [Full Text] [Related]  

  • 3. [Peripheral vasodilators in the treatment of chronic circulatory failure in ischemic heart disease patients].
    Lipnitskiĭ TN; Sheverda MG; Otkalenko IuK; Brovko AKh; Bogdanov EA
    Vrach Delo; 1986 Aug; (8):5-8. PubMed ID: 3776159
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of curantil and heparin on indices of microcirculatory and blood oxygen balance in ischemic heart disease].
    Denisiuk VI
    Vrach Delo; 1982; (10):26-9. PubMed ID: 7179876
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the therapeutic effect of a cardioactive glycoside extracted from scilla (proscillaridin A), by means of polygraphic investigations].
    Facci M
    Minerva Med; 1966 May; 57(43 Suppl):1978-82. PubMed ID: 5943255
    [No Abstract]   [Full Text] [Related]  

  • 6. [Data on the hospital treatment of heart disease patients with proscillaridin A].
    Saccabusi E
    Recenti Prog Med; 1966 Jul; 41(1):XLIII-LIV. PubMed ID: 6014476
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 1. Epidemiological situation of coronary heart disease].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1853-64. PubMed ID: 4480270
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical study of the properties of cardiac glycoside bovoside].
    Shushliapin OI
    Vrach Delo; 1976 Sep; (9):39-42. PubMed ID: 982976
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronosensitivity to cardiac glycosides in patients with circulatory insufficiency in relation to the parameters of central and peripheral hemodynamics].
    Zaslavskaia RM; Goncharov LF; Varshitskiĭ BG
    Klin Med (Mosk); 1990 Apr; 68(4):42-6. PubMed ID: 2370781
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical notes on the effect of a new cardiokinetic drug (proscillaridin A)].
    Muzio L
    Minerva Med; 1966 May; 57(43 Suppl):2005-6. PubMed ID: 5944828
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of the total left ventricular systole under the influence of cardiac glycosides with particular reference to proscillaridin A].
    Adamska-Dyniewska H
    Pol Tyg Lek; 1969 Oct; 24(40):1523-5. PubMed ID: 5365667
    [No Abstract]   [Full Text] [Related]  

  • 12. [Are cardiac glycosides advisable in the treatment of food poisoning].
    Rebenok ZhA
    Ter Arkh; 1988; 60(11):69-71. PubMed ID: 3238582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Some clinical observations on the use of a cardiokinetic extract of squill: proscillaridin A. Differences from other more commonly used glycosides].
    Luise A
    Minerva Med; 1967 Dec; 58(96):4286-9. PubMed ID: 6083290
    [No Abstract]   [Full Text] [Related]  

  • 14. [Actihaemyl as adjuvant in cardiac therapy].
    Lordick H
    Munch Med Wochenschr; 1970 Feb; 112(7):298-300. PubMed ID: 5537795
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical use of a new cardioactive glycoside: proscillaridin A].
    Tronconi L; Storti D
    Minerva Med; 1966 May; 57(43 Suppl):2011-7. PubMed ID: 5944829
    [No Abstract]   [Full Text] [Related]  

  • 16. [Certain problems of the organization of control of ischemic (coronary) heart disease].
    Il'inskiĭ BV
    Klin Med (Mosk); 1974; 52(8):141-4. PubMed ID: 4424420
    [No Abstract]   [Full Text] [Related]  

  • 17. [Problems in the use of cardiac glycosides in ischemic heart disease].
    Modersohn D; Urbaszek W
    Z Gesamte Inn Med; 1975 Aug; 30(15):502-6. PubMed ID: 1189495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical observations on the use of a new cardioactive glycoside: proscillaridin A].
    Martinetti L; Lai G
    Minerva Med; 1966 May; 57(43 Suppl):1994-9. PubMed ID: 5943258
    [No Abstract]   [Full Text] [Related]  

  • 19. [Ambulatory treatment of chronic cardiac insufficiency with prolonged administration of nitrates].
    Kots IaI; Solonovich TG
    Sov Med; 1989; (8):64-6. PubMed ID: 2510324
    [No Abstract]   [Full Text] [Related]  

  • 20. [The antiarrhythmic and coronary-dilating properties of verapamil in patients ith ischemic heart disease].
    Votcal BE; Lozinskij LG; Goldberg VA; Venediktova MG; Gribova OA
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1281+. PubMed ID: 5312386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.